Once again, Diario Médico has awarded Vall d’Hebron Institute of Research (VHIR) with the 'Best Health Ideas' prize, for the "http://www.vhir.org/salapremsa/mitjans/mitjans_detall.asp?Idioma=en&mv1=5&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2013&num=187" opening of an exclusive space dedicated to clinical research. The head of the Support Unit to Clinical Research (USIC), Inma Fuentes, and the responsible of the Promotion Unit of Clinical Trials and Clincal Research, Xavier Molina, received the prize in the ceremony hosted on November 18, at the National Theatre of Catalonia. VHIR, international leader in the development of clinical trials, opened on July an exclusive space of 625m2 for the USIC. Located at the 13th floor of the Mother and Child area, it has 7 consulting rooms, an extraction room, a laboratory for sample management and temporal conservation and a temporal drug storage among other facilities to monitor and control external patients who take part in clinical trials. At the same time, the 13th floor will host the Academic Research Organisation (ARO), which will offer to researchers a complete package of management services, such as medical writing, administrative procedures for study approval, project management and monitoring, data management and statistical analysis of the results.Whereas in Europe the average of clinical trials has decreased 25-30%, at VHIR have slightly increased. The new facilities could host nearly 350 clinical trials of phase II, III and IV and could attend 5,000 patients per year. At the present time, VHIR has nearly 600 clinical trials in course and important agreements with the main pharmaceutical companies, such as Pfizer, Sanofi, Bristol-Meyers Squibb and Quintiles.